Schema depicting treatment schedule for modules 1 (durvalumab–olaparib), 2 (durvalumab–danvatirsen) and 3 (durvalumab–ceralasertib), showing durvalumab administration (blue arrows), combination agent dosing (continuous colored bars), and pretreatment/on-treatment blood sample collection time points (stars). BID, twice daily.
